More on: Intensive factor VIII exposure and inhibitor development in mild hemophilia A [6]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 4, 2004, Pages 677-

  Carcao, Manuel D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR;

BLEEDING; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EXPOSURE; HEMOPHILIA A; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR;

EID: 19944430440     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00679.x     Document Type: Letter

References (2)

1. Koestenberger M, Leschnik B, Muntean W. More on: mild hemophila A and inhibitor development. J Thromb Haemost 2004; 2 676.
2. Sharathkumar A, Lillicrap D, Blanchette S, Kern M, Leggo J, Stain M, Brooker L, Carcao MD. Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost 2003; 1: 1228-36.